gMendel® establishes Board of Directors and announces Appointments

gMendel® establishes Board of Directors and announces Appointments November 15, 2022, Copenhagen – gMendel® announced today its first Board of Directors. The company is also pleased to announce the appointments of Lars Staal Wegner, Chairman, and Hanna Pyokari,...

gMendel® joins TechBBQ Summit in Copenhagen

gMendel® joins TechBBQ Summit in Copenhagen   August 29, 2022, Copenhagen – gMendel® will join TechBBQ Summit on 14 and 15 September in Copenhagen to showcase its breakthrough technology for the diagnosis of genetic disorders. TechBBQ is a collaboration and...

Artificial Intelligence in healthcare: the case of Denmark

Denmark’s vision to become a front-runner in the use of artificial intelligence reflects on the country’s national strategy for AI.   Following the European Commission’s action plan for artificial intelligence in 2018, Denmark has been quick to grasp...

gMendel® announces CE marking for its Phivea® v1.0.0 platform

gMendel® announces CE marking for its Phivea® v1.0.0 platform   May 6, 2022, Copenhagen – gMendel® announced today it has achieved CE marking for its Phivea® v1.0.0 platform, a novel screening technology for the detection of Klinefelter Syndrome. Following...